ENDO 2020 Suggestions
Mark your calendars for ENDO 2020 in San Francisco, CA, March 28–31, 2020. Help us create an innovative meeting by submitting your suggestions through our ENDO 2020 suggestion site.
New! MTP 2019
Improve your patient care with this brand-new case-based book. Examine summaries of cases discussed during the live Meet-the-Professor sessions from ENDO 2019, and earn 30.0 AMA PRA Category 1 Credits™.
Registration for Endcorine Board Review (EBR) and Clinical Endocrinology Update (CEU) 2019 is now open! EBR and CEU are coming to Seattle, Washington, Sept. 17-21. CEU will also be in Miami, Florida, Sept. 5-7. Register today!
Diabetes in Older Adults CPGconsideration the overall health and quality of life of older individuals with diabetes.
April Thematic Issue
This month we are highlighting the latest updates in neuroendocrinology with a special collection of journal articles, published in 2017—2019. This free online collection features notable basic and clinical findings from our family of journals.
- Advocacy in Action: EDCs in Europe, E/M Codes, Diabetes Test Strips and more...
- Q&A: Clifford Rosen, MD: Practice Guideline on Pharmacological Treatment of Osteoporosis in Post-Menopausal Women.
- Genetic Studies Provide Possible Mechanistic Link Between Endometriosis and Ovarian Cancer
- Lab Notes Q&A: Charis Eng, MD, PhD—A discussion of her research of tumor suppressor genes, endocrine neoplasias, and why an accurate family history is so important to determine when a cancer screening should be performed.
- NEW CPG: Pharmacological Management of Osteoporosis in Postmenopausal Women
- NEW CPG: Treatment of Diabetes in Older Adults
The Endocrine News Podcast caught up with Anuja Dokras MD, PhD, at ENDO 2019 to discuss PCOS, Race, and Anxiety.
Visit Us at Upcoming Meetings!
We are proud to support other organizations that are devoted to endocrine-related science and medicine. Plan to visit our booth at one the following meetings:
- American Association of Clinical Endocrinologists: April 24-28, Los Angeles Convention Center & JW Marriott, Los Angeles, CA, USA, Booth # 347
- Pediatric Academic Societies: April 27-30, Baltimore Convention Center, Baltimore, MD, USA, Booth # 950
- European Congress of Endocrinology: May 18-21, Lyon Convention Center, Lyon, France, Stand # A14
- American Diabetes Association: June 7-11, Moscone Convention Center, San Francisco, CA, USA, Booth # 116
We look forward to seeing you!
- May 3 - 5, 2019 | Endocrine and Diabetes Controversies in Adult Primary Care Practice | Brewster, MA, United States
- May 20 - 25, 2019 | Workshop on SEX DIFFERENCES IN BRAIN AND BEHAVIOR IN HEALTH AND DISEASE | Erice, Sicily, Italy
- May 22 - 24, 2019 | 1st International Diabetes Congress Cuba 2019 | Havana, Cuba
Claim CME and MOC Credits with Ease
Please provide your feedback, complete the evaluation and claim your credits or print your certificate of attendance online at the Center for Learning.
Visit endodaily.org to find coverage of ENDO 2019 sessions and meeting news. Find out what you missed and get highlights from a variety of sessions.
- Senescence Plenary Outlines New Targets for Age-Related Diseases
- Osteoporosis Clinical Practice Guideline Emphasizes Importance of Treatment, Patient Preferences
- Former FDA Commissioner Outlines How Big Data Will Change Health and Healthcare Delivery
- Plenary Outlines New Pathway in Cellular and Systemic Lipid Homeostasis
- Putting CRISPR Screens to Work in Epigenetic Landscapes
- Symposium Addresses Needed Changes to Gender Bias, Inequity in the Specialty
Our findings demonstrate that Kiss1r is necessary to the effect of kisspeptin on prolactin secretion, although TIDA neurons lack Kiss1r and are electrically unresponsive to kisspeptin.
Evidence supports a role for fibrocytes in the pathogenesis of TAO. Recognition of their presence in the orbit now allows development of therapies specifically targeting these cells that ultimately could allow the restoration of immune tolerance within the orbit and perhaps systemically.
This review offers some guiding principles for the application of free testosterone measurements in the diagnosis and treatment of patients with androgen disorders.
We identified 33 candidate driver genes of sporadic PC, in addition to previously known driver genes CDC73 and MEN1.